What is Evolent Health?
Specialty care management and value-based health services company with 2026 revenue growth outlook of approximately 30% scale.
- Category
- Specialty care management and value-based health services
- Headquarters
- Arlington, VA
- Founded
- 2011
- Employees
- 4,500+
- Total funding
- Public company; not venture-round led
- Status
- NYSE: EVH
What is Evolent Health?
Evolent Health is a Specialty care management and value-based health services company headquartered in Arlington, VA. As of June 2026, its clearest scale signal is 2026 revenue growth outlook of approximately 30%.
Evolent Health operates a specialty care management platform supporting payers and risk-bearing providers in oncology, cardiology, musculoskeletal, advanced imaging, and administrative services. Its core customer set includes health plans, risk-bearing provider groups, specialty networks, Medicare Advantage plans, Medicaid plans, and commercial payers, and its public product surface includes Performance Suite, Specialty Technology and Services Suite, Administrative Services, Oncology care management, Cardiology management. The current scale signal is 2026 revenue growth outlook of approximately 30%, which makes this a mid-market public account with real enterprise procurement capacity rather than an early-stage startup.
The company competes where healthcare buyers care about evidence, reliability, compliance, integrations, and measurable operational or clinical outcomes. Vendor evaluation usually involves business owners plus finance, security, legal, procurement, data, clinical, quality, compliance, and IT stakeholders.
For sellers, the account should be approached as a public-company buying center. The strongest angles connect directly to growth, retention, margin expansion, reimbursement, quality, member or patient experience, regulated data handling, workflow automation, or lower cost to serve.
What does Evolent Health offer?
Evolent Health offers Performance Suite, Specialty Technology and Services Suite, Administrative Services, Oncology care management and related healthcare workflows.
- Performance Suite· Core product
- Specialty Technology and Services Suite· Core product
- Administrative Services· Core product
- Oncology care management· Workflow
- Cardiology management· Workflow
- Musculoskeletal management· Workflow
- Advanced imaging· Platform
- Value-based specialty contracts· Platform
How does Evolent Health make money?
Evolent earns service, technology, and performance-based revenue from health-plan and provider customers that outsource specialty-care cost and quality management.
Evolent earns service, technology, and performance-based revenue from health-plan and provider customers that outsource specialty-care cost and quality management. Growth is driven by the same operating levers buyers track internally: customer volume, recurring revenue, utilization, reimbursement, renewal rates, attach rates, product expansion, and disciplined cost control.
Contracts are negotiated by covered lives, specialty category, risk arrangement, delegated scope, savings share, case volume, and implementation requirements. In practice, commercial packaging usually separates strategic enterprise accounts, standard commercial customers, implementation services, support, usage, and renewal economics.
For a seller, budget access depends on showing a near-term connection to revenue capture, margin improvement, compliance, uptime, provider or member experience, data quality, clinical evidence, or workflow throughput. Generic efficiency claims are weaker than quantified impact on one of those operating levers.
Who leads Evolent Health?
Evolent Health is led by Seth Blackley, with finance, product, clinical, technology, commercial, and operations leaders influencing major vendor decisions.
- Seth BlackleyCo-founder and Chief Executive OfficerCEO since 2020Leads the specialty-care strategy and value-based contract model.
- John JohnsonChief Financial OfficerCFOOwns finance, guidance, and capital allocation.
- Chris DaweChief Administrative OfficerExecutive leaderSupports operations, policy, and administrative execution.
- Dan McCarthyPresidentSenior executiveLeads growth and operational delivery across specialty offerings.
How do you contact Evolent Health's leadership?
Evolent Health publishes an official investor-relations or corporate contact route, but this profile does not present guessed personal executive emails as verified. Use the official contact listed here, the company contact page, or a relationship-based introduction for executive outreach.
ir@evolent.com (official published/company IR contact); personal executive format not verifiedHow much funding has Evolent Health raised?
Evolent Health is a public company (NYSE: EVH), so the current capital story is public-market status, operating cash flow, debt or equity access, and acquisitions rather than a private startup round stack.
2011: Founded - Evolent is founded to support value-based care transformation. 2015: IPO - Evolent lists publicly on the NYSE. 2020: Specialty focus - The company sharpens strategy around specialty care management. 2023: NIA integration - Evolent expands specialty technology and services through National Imaging Associates assets. 2026: 2026 outlook - Management points to approximately 30% total forecasted revenue growth for 2026.
As of June 2026, Evolent Health's practical funding capacity is best read through NYSE: EVH, 2026 revenue growth outlook of approximately 30%, its latest annual or quarterly filings, cash flow, balance sheet, and guidance. For public mid-market healthcare companies, the next budget cycle is usually governed by operating plans and investor commitments, not by a new venture round.
Seller signal: public-company status gives Evolent Health access to mature procurement and repeat budget cycles, but it also raises the proof bar. Successful pitches need a measurable business case, clean implementation plan, security and compliance readiness, and executive sponsorship from the functional owner.
How did Evolent Health get here?
Evolent Health grew through founding, product expansion, public-market milestones, and its latest June 2026 operating update.
- 2011Company foundedEvolent begins as a value-based care enablement company.
- 2015Public listingEvolent lists on NYSE.
- 2021Specialty pivotManagement emphasizes specialty-care value economics.
- 2023NIA acquisition closesThe company adds advanced imaging and specialty-management scale.
- 2025Performance Suite renewalsEvolent reports customer renewals and migration to enhanced contracts.
- 2026Q1 2026 resultsEvolent reports first-quarter 2026 results and maintains specialty growth focus.
Who are Evolent Health's competitors?
Evolent Health competes with public companies, private healthcare platforms, software vendors, services firms, and specialized workflow providers depending on the buyer's problem.
- AledadeIndependent-primary-care value-based care network and enablement platform.
- VillageMDPrimary-care provider platform with clinics and value-based contracts.
- OptumLargest payer-services and care-management competitor.
- CarelonElevance-owned health-services platform with specialty and care-management products.
- Cohere HealthPrior authorization and specialty-management technology competitor.
- HealthEdgePayer administration and care-management software competitor.
Evolent Health — frequently asked questions
